Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis.

Marla C DubinskyVipul JairathBrian G FeaganApril N NaegeliJay TuttleNathan MorrisMingyang ShanVipin AroraTrevor LissoosNoah AgadaToshifumi HibiBruce E Sands

Published in: BMJ open gastroenterology (2023)

Mirikizumab improved HRQoL in patients with moderately-to-severely active UC.

Keyphrases

ulcerative colitis
open label
double blind
clinical trial
randomized controlled trial